Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
As the federal government readies its second crack at overhauling the information dealmakers must submit to regulators ahead of a planned merger, the hospital lobby is again calling for exemptions | As regulators explore an update to the Hart-Scott-Rodino form that would survive court scrutiny, the American Hospital Association argues that the existing process is doing the job.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

More than 500 hospitals falling short on price transparency requirements have received warnings from the federal government since…

The Trump administration unveiled new efforts to strengthen oversight of the Trusted Exchange Framework and Common Agreement…

Just hours after the Trump administration announced action against fraud in the hospice and home health spaces, Vice President JD…

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, payers and other industry players…

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, payers and other industry players…

The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers…